Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity-Reference-Cited by-同舟云学术

Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity

Published:2018-09 Issue:3 Volume:34 Page:466-482.e6
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Dravis Christopher,Chung Chi-Yeh,Lytle Nikki K.,Herrera-Valdez Jaslem,Luna Gidsela,Trejo Christy L.,Reya Tannishtha,Wahl Geoffrey M.

Funder

Cancer Center Core

NIH

Susan G. Komen Foundation

BCRF

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference63 articles.

1. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation;Asselin-Labat;Nat. Cell Biol.,2007

2. Multipotent luminal mammary cancer stem cells model tumor heterogeneity;Bao;Breast Cancer Res.,2015

3. A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63;Bao;Genome Biol.,2015

4. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks;Bindea;Bioinformatics,2009

5. Bolstad, B. (2018). preprocessCore: A Collection of Pre-processing Functions. R package version 1.40.0, https://github.com/bmbolstad/preprocessCore.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation;npj Breast Cancer;2024-09-14

2. Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer;iScience;2024-07

3. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer;British Journal of Cancer;2024-05-17

4. Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer;2024-04-20

5. First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors;The Oncologist;2024-01-31